KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Incorporating Multiple Imputation Into Tanezumab Dose-Response Modeling of WOMAC Pain CFB Across Six Randomized Placebo-Controlled Phase 3 Trials.

Martin Boucher, Scott Marshall, Puneet Gaitonde

CPT Pharmacometrics Syst Pharmacol 14(9) 1485-1493

PMID40566820
PMCIDPMC12439290
DOI10.1002/psp4.70070
发表日期2025-06-26
摘要

摘要

Multiple imputation is increasingly being used to deal with missing data in clinical trials. It is a simulation approach leading to multiple analyses of a pre-defined number of datasets. For a pre-defined statistical model, this is relatively straightforward, but for model development as typically conducted in Pharmacometrics, it is unclear how such an approach could be implemented. This case study describes how this was addressed at the time of a regulatory submission and considers alternative approaches which could be adopted in the future.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。